Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report

References

• Uttley L, Carroll C, Wong R, et al. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20(1):e2–e10.
   PubMed Web of Science ®Google Scholar
• Román GC, Spencer PS, Reis J, et al. The neurology of COVID-19 revisited: a proposal from the environmental neurology specialty group of the world federation of neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884.
   PubMed Web of Science ®Google Scholar
• Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91(4):e331–e338.
   PubMed Web of Science ®Google Scholar
• Young MJ, O’Hare M, Matiello M, et al. Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav Immun. 2020;89:601–603.
   PubMed Web of Science ®Google Scholar
• Tayyebi G, Malakouti SK, Shariati B, et al. COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report. Neurodegener Dis Manag. 2022;12(1):29–34.
   PubMed Web of Science ®Google Scholar
• Watson N, Kirby J, Kurudzhu H, et al. Impact of the COVID-19 pandemic on Creutzfeldt-Jakob disease surveillance and patient care in the United Kingdom. Eur J Neurol. 2021 Dec 23;294:1222–1226. cited 2021 Feb 25.
   Web of Science ®Google Scholar
• Jones E, Mead S. Genetic risk factors for Creutzfeldt-Jakob disease. Neurobiol Dis. 2020;142:104973.
   PubMed Web of Science ®Google Scholar
• Stoeck K, Bodemer M, Ciesielczyk B, et al. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol. 2005;62(10):1591–1594.
   PubMedGoogle Scholar
• Stoeck K, Bodemer M, Zerr I. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol. 2006;172(1–2):175–181.
   PubMed Web of Science ®Google Scholar
• Fujita K, Matsui N, Takahashi Y, et al. Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia. J Neuroinflammation. 2013;10(1):135.
   PubMedGoogle Scholar
• Guasp M, Muñoz-Sánchez G, Martínez-Hernández E, et al. CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front Immunol. 2022;13:866153.
   PubMed Web of Science ®Google Scholar
• Schenkel C, Aguzzi A. Prions, prionoids and protein misfolding disorders. Nat Rev Genet. 2018;19(7):405–418.
   PubMed Web of Science ®Google Scholar
• Hara H, Chida J, Uchiyama K, et al. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Sci Rep. 2021;11(1):10109.
   PubMed Web of Science ®Google Scholar
• De Chiara G, Marcocci ME, Sgarbanti E, et al. Infectious agents and neurodegeneration. Mol Neurobiol. 2012;46(3):614–638.
   PubMed Web of Science ®Google Scholar
• Ashraf GM, Tarasov VV, Makhmutova A, et al. The possibility of an infectious etiology of Alzheimer disease. Mol Neurobiol. 2019;56(6):4479–4491.
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224–233.
   PubMed Web of Science ®Google Scholar
• Cosentino G, Todisco M, Hota N, et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol. 2021;28(11):3856–3865.
   PubMed Web of Science ®Google Scholar
• Idrees D, Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration. Biochem Biophys Res Commun. 2021;554:94–98.
   PubMed Web of Science ®Google Scholar
• Creutzfeldt-Jakob disease international surveillance network [Internet]. Edinburgh (Scotland UK): European Centre for Disease Prevention and Control; 2022. [cited 2022 Feb 25]. Available from: https://www.eurocjd.ed.ac.uk/data_tables
   Google Scholar
• Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013;2(5):38–43.
   PubMedGoogle Scholar